Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Resource Type
Article
Authors
Skinner, S Rachel ; Szarewski, Anne ; Romanowski, Barbara ; Garland, Suzanne M ; Lazcano-Ponce, Eduardo ; Salmerón, Jorge ; Del Rosario-Raymundo, M Rowena ; Verheijen, René H M ; Quek, Swee Chong ; da Silva, Daniel P ; Kitchener, Henry ; Fong, Kah Leng ; Bouchard, Céline ; Money, Deborah M ; Ilancheran, Arunachalam ; Cruickshank, Margaret E ; Levin, Myron J ; Chatterjee, Archana ; Stapleton, Jack T ; Martens, Mark ; Quint, Wim ; David, Marie-Pierre ; Meric, Dorothée ; Hardt, Karin ; Descamps, Dominique ; Geeraerts, Brecht ; Struyf, Frank ; Dubin, Gary
Source
In The Lancet 20 December 2014-2 January 2015 384(9961):2213-2227
Subject
Primary Research Articles
Language
ISSN
0140-6736